Reed's, Inc. Exhibits at American Society of Clinical Oncology (ASCO) 2009 Annual Meeting

Study Findings Released Showing Ginger Provides Significant Reduction of Chemotherapy-Induced Nausea

Share Email this page  |  Print page  |  Share Share this page

LOS ANGELES, CA--(Marketwire - June 2, 2009) - Reed's, Inc. (NASDAQ: REED), maker of the top-selling sodas in natural food stores nationwide, announced today that it exhibited at the ASCO 2009 Annual Meeting. Founded in 1964, the American Society of Clinical Oncology (ASCO) is the world's leading professional organization representing physicians who treat people with cancer. ASCO released the official findings of a study funded by the National Cancer Institute on the effects of ginger on post-chemo nausea at the meeting.

The ASCO Annual Meeting is considered the premier educational and scientific event in the oncology community. More than 26,000 professionals attended the educational and scientific sessions that offered cutting-edge information on the diagnosis and treatment of patients with cancer.

"It was exciting to be there alongside companies that provide cancer treatments and support services," stated Mr. Chris Reed, Founder and CEO of Reed's, Inc. "The original intent of this company was to be able to help people by providing a ginger tonic disguised as a soft drink. It's great to get validation from the medical industry on the effectiveness of ginger in treating nausea. I'm pretty sure we're the first soft drink company to find our all-natural main ingredient competing with drugs."

Reed added, "It's nice to be valued as more than just a fun, thirst-quenching beverage company. Ginger has many other traditional uses and seems to be attracting more and more research. I have seen numerous studies around ginger and its cancer-fighting properties; I have seen medical studies where ginger beats Dramamine, a popular motion sickness drug. In Europe, they use ginger for arthritis due to its anti-inflammatory properties. I hear from customers that are using it to relieve migraines and other inflammation conditions. Ginger is one folk medicine that seems to hold up to medical scrutiny."

"We get a pretty steady stream of people emailing to tell us how well our drinks work in helping them overcome nausea and digestive complaints and particularly post-chemo nausea. We will continue to expand on the many contacts we have received at this show to help promote our drink's benefits to the oncology industry," concluded Reed.

About Reed's, Inc.

Reed's, Inc. makes the top selling sodas in natural food markets nationwide and is currently selling in 10,500 supermarkets in natural foods and mainstream. Its six award-winning non-alcoholic Ginger Brews are unique in the beverage industry, being brewed, not manufactured and using fresh ginger, spices and fruits in a brewing process that predates commercial soft drinks. In addition, the Company owns the top selling root beer line in natural foods, the Virgil's Root Beer product line, and the top selling cola line in natural foods, the China Cola product line. Other product lines include: Reed's Ginger Candies and Reed's Ginger Ice Creams.

Reed's products are sold through specialty gourmet and natural food stores, mainstream supermarket chains, retail stores and restaurants nationwide, and in Canada. For more information about Reed's, please visit the company's website at: or call 800-99-REEDS.

Follow Reed's on Twitter at:

View Reed's YouTube channel at:

Review Reed's Delicious bookmarks at:

Join Reed's Facebook Fan Page at:

Subscribe to Reed's RSS feed at:

More information can be found at:


Some portions of this press release, particularly those describing Reed's goals and strategies, contain "forward-looking statements." These forward-looking statements can generally be identified as such because the context of the statement will include words, such as "expects," "should," "believes," "anticipates" or words of similar import. Similarly, statements that describe future plans, objectives or goals are also forward-looking statements. While Reed's is working to achieve those goals and strategies, actual results could differ materially from those projected in the forward-looking statements as a result of a number of risks and uncertainties. These risks and uncertainties include difficulty in marketing its products and services, maintaining and protecting brand recognition, the need for significant capital, dependence on third party distributors, dependence on third party brewers, increasing costs of fuel and freight, protection of intellectual property, competition and other factors, any of which could have an adverse effect on the business plans of Reed's, its reputation in the industry or its expected financial return from operations and results of operations. In light of significant risks and uncertainties inherent in forward-looking statements included herein, the inclusion of such statements should not be regarded as a representation by Reed's that they will achieve such forward-looking statements. For further details and a discussion of these and other risks and uncertainties, please see our most recent reports on Form 10-KSB and Form 10-Q, as filed with the Securities and Exchange Commission, as they may be amended from time to time. Reed's undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events, or otherwise.

Contact IRTH Communications, LLC Mark B. Moline Managing Partner 760-458-4899 Email Contact